News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
The inaugural NIH Start-up Licenses program has been so successful that the Office of Technology Transfer (OTT) had decided to extend it for another year. From the start of the program on October 1, 2011 to September 12, 2012, we have executed five licenses and have a number in the process of
The National Cancer Institute is currently soliciting proposals for two contract funding opportunities in cancer technologies through the SBIR-TT Program. Details on each proposal may be found by clicking on the individual Contract Topics below. NCI SBIR Contract Topic 317 — Wound Healing
A new website is now available to find technologies related to rare diseases or conditions across 30 of the Clinical Translation Science Award (CTSA) institutions and NIH. The CTSA institutions are funded by NIH as part of a program designed to spur the transformation of clinical and translational